More PRNewswire
View Older Stories View Newer Stories-
Asia's Leading Hardware Sourcing Fair CIHS 2026 Set to Connect Global Markets in Shanghai
-
WuXi Biologics Ireland Wins Top Honors at the 2026 Life Sciences Industry Awards
-
Desert-bred wheat from Sharjah outperforms global standards as demand grows for climate-resilient crops
-
Coachella Takes the Crown: U.S. Festivals Dominate the Inaugural 'Global Festival Attractiveness Index' ('Yanolja Festival Index')
-
sweelin® Clinical Trial Results Published in Leading Journal, Food Chemistry, Confirming Blood Glucose Safety
-
Curasight Announces Preliminary Readout from its Phase 1 Clinical Trial with uTREAT® in Aggressive Brain Cancer (Glioblastoma)
-
PATEO Teams Up with Xunce Technology and Saimo Technology to Define a New Paradigm for In-Vehicle AI Value Exchange
-
LG Teams with NVIDIA to Shape the Future with M.A.P. (Mobility / AI Infra / Physical AI)
-
TARS Brings Real-Life Embodied AI to ICRA 2026 Robotics Conference
-
DL Holdings' Fourth "Victoria Harbour Night Talk": The AI Wave: Global Investment & Hong Kong Opportunities
-
GoveeLife Launches Smart Countertop Ice Maker 2 Pro for Iced Coffee and Summer Hosting
-
Real Estate Firm New York Residence, Inc. Visits Netherlands, Belgium, & Croatia
-
ROHM's SiC MOSFET Adopted in BBU for AI Servers as HVDC Architectures Advance
-
Tethis to launch SmartBioSurface® slides at EACR Conference
-
Lumos Insurance Names Tom Kenny Managing Director and Senior Vice President of Global Retirement and Protection
-
Share buybacks in Ericsson during the period June 1 - June 5, 2026
-
Aker BP increases ownership interest in Johan Sverdrup following redetermination
-
Musim Mas Earns CDP 'A' for Advancing Supplier Engagement Across Its Value Chain
-
New Linux Foundation Report Finds AI is Driving Positive Tech Hiring Trends in Europe Amid Growing Security and Skills Gaps
-
Sinch appoints Jonas Dahlberg as acting CEO to lead next phase of execution and growth
-
Everything-PR Names the 100 People Shaping What AI Engines Say
-
Carnegie Mellon Alumna Earns Tony Award for Best Musical
-
Winning firms will focus on what they can control, weather the rest, as triple-shock brakes private equity's latest revival --Bain & Company 2026 Midyear PE report
-
New IBM Study Finds CIOs and CTOs Face Growing AI Control Gap as Enterprise Deployment Scales
-
A Banner Year for Banks--and the Moment to Shift Gears on Growth, AI, and Innovation
-
For Decades, International Bodies Warned Germany Over Its Treatment of Scientologists
-
GIGABYTE Advances Motherboard Performance with AI-driven Technologies
-
HTX Launches "Appreciation Program" with Over $10 Million to Reward User Trust
-
Unisound Releases U2: A Native Agentic Large Model Built for Execution, Capable of Autonomously Decomposing and Completing 100+ Steps in Complex Real-World Workflows
-
Vi Appoints Spencer Honeyman as President, Global Growth
-
Xinhua Silk Road: Posidonia China Night provides high-level platform for int'l maritime exchange, cooperation
-
Dayspring Pharma Announces Positive Topline Results from Phase II Clinical Trial of CG2001 for the Treatment of Androgenetic Alopecia (AGA)
-
New Report "Early Bird" Maps Tech Investing for Asian Family Offices
-
GIGABYTE Advances Gaming Monitor Technologies with AI-optimized Visuals and Automatic OLED Protection
-
Anamana Incubator Targets Culturally Native Creators to Diversify Homogenized Micro-Drama Market
-
Uhale Adopts Quokka's Q-mast to Strengthen Application Security Testing
-
Ascletis Reinforces Its Differentiated Obesity Portfolio at American Diabetes Association (ADA) 2026 Scientific Sessions, Showcasing ASC30 Clinical Data and Exciting Preclinical Findings from ASC37 an
-
OriCell's GPC3 CAR-T Receives NMPA Clearance for Confirmatory Phase II Trial in Late-Line Advanced Hepatocellular Carcinoma
-
Antengene Presented First Preclinical Data at EULAR 2026 Showing ATG-207 Promotes Regulatory T Cell Induction and Immune Tolerance
-
VolitionRx Announces Pricing of $4.6 Million Public Offering
-
Novo Nordisk's CagriSema 2.4 mg / 2.4 mg demonstrated significant reduction in HbA1c and weight across multiple studies in the REIMAGINE program presented at ADA 2026
-
Once-Weekly CagriSema (Amylin-Semaglutide) Combination Injection More Effective than Standalone Medications
-
AMGEN PRESENTS NEW DATA ACROSS ITS CARDIOMETABOLIC PORTFOLIO AT AMERICAN DIABETES ASSOCIATION 86TH SCIENTIFIC SESSIONS
-
Lipid-Lowering Medications Demonstrate Cardiometabolic Benefits in Populations with High-Risk Diabetes
-
Once-Weekly Drug Demonstrates Promising Dual Benefits in Obesity and Metabolic Health
-
Head-to-head Study Validates the Clinical Advantage of New-generation Biased GLP-1: Ecnoglutide Delivers 35% Greater Weight Loss than Semaglutide
-
Lilly's Foundayo (orforglipron), the only oral GLP-1 taken without food or water restrictions, was associated with significant weight loss in women at every stage of menopause
-
MimiSilk Marks 12 Years of Advanced Care with New Product Launches and Anniversary Sale
-
Soules Kitchen Declares June 7th (6/7) the Official Day of Delightful Dinners
-
Wegovy® pill prescriptions surpass 3 million, 1 filled roughly every 5 seconds, bringing GLP-1 therapy to people with obesity previously untreated, while Novo Nordisk unveils new data at ADA 2026
